Results
Welcure Drugs FY26 Audited Results Show ₹549 Lakh Loss
Welcure Drugs reported audited FY26 standalone net loss of ₹549.01 lakhs versus ₹278.01 lakh profit previous year.
Auditors issued unmodified opinion but highlighted major qualifications including unv
